Markets

Biotech ETFs Could Heat Up Thanks to Republican-Led Congress

The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets, and the rival SPDR S&P Biotech ETF (NYSEArca: XBI) are performing well this year. Underscoring that point, the two widely followed biotech ETFs are up an average of 20.5% year-to-date and some traders believe biotechnology stocks and ETFs will continue… Click to read more at ETFtrends.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article was provided by our partner Tom Lydon of etftrends.com.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

ETFs